# What to bring when your joint gets checked *How Diagnosis Changes Care | arthritis treatment phoenix* > Learn which arthritis symptoms matter and what an exam may include in this arthritis treatment phoenix guide. This page tells you what happens during a joint visit. The exam comes first. Tests are useful when they can change your care. ## What to write down before you go Note whether the soreness began fast or crept in. Write down which joints hurt and when stiffness eases. Mention swelling, warmth, fever, rash, or a recent injury. Your notes don't need medical words. Choose one daily activity you want to do more easily. It might be walking through a store or sleeping well. Bring your medicine list and old joint reports. These details give the provider a clear place to start. ## What to expect during the visit The provider will check warmth, swelling, motion, strength, and sore areas. Soreness beside the joint can come from a tendon or nearby tissue. X-rays reveal changes in bone and joint space. They can't measure how much you hurt or what you can do. During a QC Kinetix consultation, medical providers examine your joint and discuss earlier care. They'll explain regenerative treatments that use your blood after preparation. These blood-based choices are also called orthobiologics. Ask what happens during treatment and how often you'll return. ## When to ask what a test will change Blood tests can look for immune activity linked with rheumatoid disease. They can also measure uric acid when gout is possible. Joint fluid may need testing when sudden warmth and swelling lack a clear cause. Ask what each result could change about your care. After injury, an X-ray can reveal bone damage. It may also help when a joint locks. A small X-ray change doesn't make severe soreness unimportant. A worn-looking joint doesn't make surgery the only choice either. ## Sources 1. The 2010 ACR/EULAR classification criteria define 'definite rheumatoid arthritis' by confirmed synovitis in at least one joint, absence of a better alternative diagnosis, and a total score of 6 or more out of 10 across four domains: number and site of involved joints (0-5), serology (0-3), acute-phase response (0-1) and symptom duration (0-1). This is the formal boundary between inflammatory arthritis and degenerative joint disease. Aletaha D, et al. — [2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.](https://pubmed.ncbi.nlm.nih.gov/20872595/). *Arthritis Rheum*, 2010. DOI: 10.1002/art.27584. 2. In the Framingham Osteoarthritis Study, 710 people over 50 with NO radiographic evidence of knee osteoarthritis underwent knee MRI: 89% had 'any abnormality'. Osteophytes appeared in 74%, cartilage damage in 69% and bone marrow lesions in 52%. Prevalence of at least one abnormality was 90-97% in painful knees and 86-88% in painLESS knees. Guermazi A, et al. — [Prevalence of abnormalities in knees detected by MRI in adults without knee osteoarthritis: population based observational study (Framingham Osteoarthritis Study).](https://pubmed.ncbi.nlm.nih.gov/22932918/). *BMJ*, 2012. DOI: 10.1136/bmj.e5339. 3. The systematic literature review informing the 2018 EULAR hand osteoarthritis recommendations (127 references) found hand exercise and prolonged thumb-base splinting beneficial, topical and oral NSAIDs equally effective with fewer adverse events from topical, and NO clear benefit for paracetamol, intra-articular thumb-base glucocorticoid or hyaluronic acid injection, low-dose oral glucocorticoids, hydroxychloroquine or anti-TNF. No trial compared surgery with sham or non-operative treatment. Kroon FPB, et al. — [Efficacy and safety of non-pharmacological, pharmacological and surgical treatment for hand osteoarthritis: a systematic literature review informing the 2018 update of the EULAR recommendations for the management of hand osteoarthritis.](https://pubmed.ncbi.nlm.nih.gov/30402266/). *RMD Open*, 2018. DOI: 10.1136/rmdopen-2018-000734. 4. The 2025 EULAR update recommends methotrexate, ideally combined with short-term glucocorticoids, as initial therapy for rheumatoid arthritis, within a treat-to-target strategy across conventional synthetic, biological and targeted synthetic DMARDs - a disease-modifying drug pathway that has no counterpart in osteoarthritis and which belongs to rheumatology. Smolen JS, et al. — [EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update.](https://pubmed.ncbi.nlm.nih.gov/41826212/). *Ann Rheum Dis*, 2026. DOI: 10.1016/j.ard.2026.01.023. ## What to bring when you call QC Kinetix offers a consultation at no charge through its Phoenix-area clinics. A medical provider will examine the joint and review your health. The clinic's regenerative treatments include care made from your own prepared blood. Bring your medicine list and a short note about the soreness. Add the activity you want to regain. Call (602) 837-PAIN to discuss which location works for you. Book a free consultation: --- Understand the soreness, then choose your next step. This arthritis treatment phoenix guide explains common soreness, ways to help at home, urgent signs, and choices for care. Plain help for understanding joint soreness, trying simple relief, and preparing for care. This site is operated by the owners of the QC Kinetix Phoenix-area clinics, including Banner Estrella, Scottsdale, Peoria and Chandler, and the business benefits when readers book with those locations. © 2026 The Phoenix Joint Field Guide. General education only; a clinician who can examine you should guide personal medical decisions.